JP Morgan Chase’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
Other funds holding PROK
SCM
BL
AGP
HWAM
VCM
JP Morgan Chase's PROK Position: Q1 2026 in Review
JP Morgan Chase held its ProKidney (PROK) position steady in Q1 2026 at 756 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7095.
JP Morgan Chase first reported a position in PROK in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.06M in Q1 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.
- JP Morgan Chase held 756 shares of ProKidney worth $1.23K as of Q1 2026.
- JP Morgan Chase left its ProKidney share count unchanged in Q1 2026.
- ProKidney made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7095 holding.
- JP Morgan Chase first reported a position in ProKidney in Q2 2021 and has held it in 18 quarters since.
- JP Morgan Chase's ProKidney position peaked at $4.06M in Q1 2022.
- 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.